A commonABCC2 promoter polymorphism is not a determinant of the risk of spina bifida
- 7 June 2004
- journal article
- research article
- Published by Wiley in Birth Defects Research Part A: Clinical and Molecular Teratology
- Vol. 70 (6) , 396-399
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Homocysteine remethylation enzyme polymorphisms and increased risks for neural tube defectsMolecular Genetics and Metabolism, 2003
- Testing for Linkage Disequilibrium, Maternal Effects, and Imprinting with (In)complete Case-Parent Triads, by Use of the Computer Program LEMThe American Journal of Human Genetics, 2000
- Prevention of Neural-Tube Defects with Folic Acid in ChinaNew England Journal of Medicine, 1999
- A Common Variant in Methionine Synthase Reductase Combined with Low Cobalamin (Vitamin B12) Increases Risk for Spina BifidaMolecular Genetics and Metabolism, 1999
- Impaired Regeneration of Monoglutamyl Tetrahydrofolate Leads to Cellular Folate Depletion in Mothers Affected by a Spina Bifida PregnancyMolecular Genetics and Metabolism, 1998
- A Log-Linear Approach to Case-Parent–Triad Data: Assessing Effects of Disease Genes That Act Either Directly or through Maternal Effects and That May Be Subject to Parental ImprintingThe American Journal of Human Genetics, 1998
- Congenital Jaundice in Rats with a Mutation in a Multidrug Resistance-Associated Protein GeneScience, 1996
- Neural tube defects and elevated homocysteine levels in amniotic fluidAmerican Journal of Obstetrics and Gynecology, 1995
- Prevention of the First Occurrence of Neural-Tube Defects by Periconceptional Vitamin SupplementationNew England Journal of Medicine, 1992
- Prevention of neural tube defects: Results of the Medical Research Council Vitamin StudyThe Lancet, 1991